Treatment with Endothelinantagonist to tcpc patients; a multicenter, randomized, Prospective study measuring maximal O2 uptake in ergometer bicycle test

Trial Profile

Treatment with Endothelinantagonist to tcpc patients; a multicenter, randomized, Prospective study measuring maximal O2 uptake in ergometer bicycle test

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Dec 2014

At a glance

  • Drugs Bosentan (Primary)
  • Indications Congenital heart defects
  • Focus Therapeutic Use
  • Acronyms TEMPO
  • Most Recent Events

    • 05 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 09 Nov 2012 Actual initiation date (12 Nov 2010) added as reported by European Clinical Trials Database record.
    • 23 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top